Search

everythinglearnresearchcommunity

for

Search:↓

Oral JAK inhibitors improved alopecia areata by modulating immune responses and boosting hair growth.

Sorafenib can cause delayed skin problems, so patients need careful monitoring.

Modulating Cytochrome P450 activity could help develop new skin disease treatments.

A compound made by Pfizer can potentially stimulate hair growth and reduce oil production, making it a good candidate for topical use.

Riboflavin 5′-phosphate (FMN) shows potential for treating androgen-related conditions but may be limited in treating prostate cancer.

New psoriasis treatments are effective but come with side effects and risks.

Liposomes show promise in cancer treatment by delivering drugs with less toxicity and improved effectiveness.

Three natural compounds from Ghanaian plants may help treat BPH and alopecia.

Immune cells boost stem cell activity in hairy moles, causing more hair growth.

Finasteride reduces melanin production, possibly treating hyperpigmentation and melanoma, but needs more safety research.

JAK inhibitors may effectively treat lichen planopilaris and frontal fibrosing alopecia with minimal side effects.

TAK-279 effectively reduces psoriasis symptoms and is safe.

JAK inhibitors show promise for treating Alopecia Areata, while statins are not recommended.

Ruxolitinib cream effectively targets and treats inflammatory skin diseases.

SH-MSCs can improve hair growth by balancing gene expressions in fluconazole-related hair loss.

Hair loss from hormone therapy in breast cancer patients can be improved with minoxidil treatment.

Old neuropharmacological drugs might be effective for treating inflammatory skin diseases.

Certain spices may help prevent and treat skin cancer, but more human trials are needed.

New compounds were made and tested, with compound 6 showing potential for treating prostate-related diseases.

MK-386 reduces sebum DHT levels.

5-Alpha reductase inhibitors may prevent prostate cancer but are not widely used due to concerns about trial relevance and potential risks, and more research is needed to confirm long-term benefits.

Nanoparticle systems make cancer treatment less toxic.

Certain immune cells in the skin release a protein that stops hair growth by keeping hair stem cells inactive.

New isatin-gallate hybrids show promise as antioxidants, cancer treatments, and coronavirus inhibitors.

5-alpha reductase inhibitors may reduce bladder cancer recurrence and improve survival.

Niosomes improve minoxidil skin delivery for hair loss treatment.

Sirtuin 1 could be a potential drug target for treating hypertrophic scars.

JAK inhibitors show promise for treating skin and hair disorders but need more research on long-term safety and effectiveness.

Minoxidil not effective in preventing chemotherapy-induced hair loss.